N-(4-(2-ethyl-4-(3-methylphenyl)-1,3-thiazol-5-yl)-2-pyridyl)benzamide,
N-(4-(2-ethyl-4-(3-methylphenyl)-5-thiazolyl)-2-pyridyl)benzamide,
TAK-715,
TAK-715,
303162-79-0,
TAK 715,
TAK715,
UNII-WE92U03C5Z,
N-(4-(2-ethyl-4-(m-tolyl)thiazol-5-yl)pyridin-2-yl)benzamide,
CHEMBL363648,
WE92U03C5Z,
Benzamide, N-[4-[2-ethyl-4-(3-methylphenyl)-5-thiazolyl]-2-pyridinyl]-,
N-[4-[2-ethyl-4-(3-methylphenyl)-1,3-thiazol-5-yl]pyridin-2-yl]benzamide,
C24H21N3OS,
N-(4-(2-ethyl-4-m-tolylthiazol-5-yl)pyridin-2-yl)benzamide,
Benzamide, N-(4-(2-ethyl-4-(3-methylphenyl)-5-thiazolyl)-2-pyridinyl)-,
N-{4-[2-ETHYL-4-(3-METHYLPHENYL)-1,3-THIAZOL-5-YL]PYRIDIN-2-YL}BENZAMIDE,
T75,
Kinome_2655,
MLS006011241,
SCHEMBL297487,
GTPL9328,
CHEBI:91360,
CTK8E7576,
KS-00001CSM,
DTXSID20184412,
SYN1087,
TAK-715/TAK715,
TAK0715,
BCPP000054,
HMS3244J06,
HMS3244J10,
HMS3244J14,
HMS3265K09,
HMS3265K10,
HMS3265L09,
HMS3265L10,
HMS3651N12,
BCP01965,
EX-A2443,
ZINC6717791,
ABP000506,
BDBM50173609,
RS0059,
s2928,
AKOS015904193,
N-(4-(2-Ethyl-4-(3-methylphenyl)-1,3-thiazol-5-yl)-2-pyridyl)benzamide,
N-(4-(2-Ethyl-4-(3-methylphenyl)-thiazol-5-yl)pyridin-2-yl)benzamide,
CS-0073,
KIN0000248,
SB19426,
compound 8h [PMID: 16162000],
NCGC00345834-01,
NCGC00345834-05,
AS-16239,
HY-10456,
QC-10454,
SMR004703001,
AB0031986,
AB1004873,
RT-015874,
TAK-715, >=98% (HPLC),
FT-0763334,
SW219195-1,
X5241,
W-5670,
J-017905,
J-523020,
BRD-K52751261-001-01-2,
I14-17006,
N-(4-(2-Ethyl-4-m-Tolylthazol-5-yl)pyrdn-2-yl)benzamde,
N-[4-[2-ethyl-4-(m-tolyl)thiazol-5-yl]-2-pyridyl]benzamide,
N-[4-(2-Ethyl-4-m-tolyl-thiazol-5-yl)-pyridin-2-yl]-benzamide,
null,
D0O6ZO,
cc-467,
CID9952773,
A8688,
A11582,
P38 MAP kinase inhibitor (rheumatoid arthritis), Takeda,